Healthcare
HK pharmaceutical market to grow steadily
The Hong Kong pharmaceutical market should reach HKD10.56 billion by 2014, up from the calculated HKD7.19 billion in 2009.
HK pharmaceutical market to grow steadily
The Hong Kong pharmaceutical market should reach HKD10.56 billion by 2014, up from the calculated HKD7.19 billion in 2009.
Hua Xia Healthcare posts third quarter profit of HK$43.6mn
The group’s acquisition of Huihao Group has become its significant income stream driver which continues to deliver satisfactory results.
Sino Biopharmaceutical profit up 16.8% to HK$320mln
The company strengthens its quality control and product development to enhance the competitiveness of its products and brand.
MicroPort raises HK$1.5bln in Hong Kong IPO
Proceeds will be used to develop new products, acquire businesses and expand company’s production facilities.
Shanghai Pharma to raise $1.2bln via HK IPO
Company to offer 25% stake to fund acquisition of rivals and sales networks.
Read Here
Advertise
Sign Up
